Maria Jimena Barroso Alverde ¹*, Isabel Noemi Torres ¹, Sion Yu ¹, Shreya Garg ² and Felipe Esparza Salazar¹

¹Investigación en Ciencias de la Salud (CICSA), FCS, Universidad Anáhuac México Campus Norte, Mexico
²Garg Multispeciality Hospital, Bathinda, India

*Corresponding Author: Maria Jimena Barroso Alverde, Investigación en Ciencias de la Salud (CICSA), FCS, Universidad Anáhuac México Campus Norte, Mexico.

Received: December 27, 2024; Published: January 08, 2025

Abstract

The article "Polycystic Ovary Syndrome (PCOS) and Ketogenic Diet: A Literature Review of the Intricate Interplay" aims to systematically assess the efficacy of the ketogenic diet in managing symptoms of PCOS, comparing it with standard dietary guidelines. The focus is on analyzing hormonal balances, metabolic changes, and symptom relief in PCOS patients adhering to a ketogenic diet. This investigation is crucial for understanding the potential of ketogenic diets as a viable, non-pharmacological treatment option for women with PCOS. The study's insights could lead to more effective dietary management strategies for this condition. In addressing the research question concerning the effectiveness of the ketogenic diet in managing symptoms of PCOS compared to standard dietary recommendations, a thorough search strategy was implemented to accumulate literature from specialized databases. Key search terms as "Polycystic Ovary Syndrome” AND “Ketogenic Diet” AND “Symptom Management” OR “Metabolic Impact" were utilized to facilitate an exploration of the PubMed database. This resulted in the identification of 32 significant numbers of records, providing a basis for the systematic review. Recent studies on dietary interventions for Polycystic Ovary Syndrome indicate that ketogenic diets, particularly very low-calorie ketogenic diets and ketogenic Mediterranean diets, have shown promising results in improving body weight, composition, metabolic profile, and hormonal levels in women with PCOS. These diets have led to significant improvements in insulin resistance and lipid profiles. The research is still in early stages, and more comprehensive studies are needed to confirm the long-term efficacy and ideal dietary patterns for managing PCOS.

Keywords: Polycystic Ovary Syndrome; Ketogenic Diet; Insulin Resistance; Hyperandrogenism and Dietary Therapy

References

1. Piltonen TT., et al. “Natural History of Polycystic Ovary Syndrome and New Advances in the Epidemiology”. Seminars in Reproductive Medicine3-04 (2021): 94-101.
2. Belenkaia LV., et al. “Criteria, phenotypes and prevalence of polycystic ovary syndrome”. Minerva Ginecology 3 (2019): 211-223.
3. Zhao H., et al. “Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment”. Journal of Ovarian Research1 (2023).
4. Escobar-Morreale HF. “Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment”. Nature Reviews Endocrinology5 (2018): 270-284.
5. Christ JP and Cedars MI. “Current guidelines for diagnosing PCOS”. Diagnostics (Basel)6 (2023): 1113.
6. Lemaitre M., et al. “Polycystic ovary syndrome and adipose tissue”. Annals of Endocrinology (Paris)2 (2023): 308-315.
7. Xu Y and Qiao J. “Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): A review of literature”. Journal of Healthcare Engineering (2022): 1-13.
8. Wang K., et al. “Androgen excess: a hallmark of polycystic ovary syndrome”. Frontiers in Endocrinology (Lausanne) 14 (2023): 1273542.
9. Moghetti P and Tosi F. “Insulin resistance and PCOS: chicken or egg?” Journal of Endocrinological Investigation 2 (2024): 233-244.
10. Herman R., et al. “Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance”. International Journal of Molecular Sciences 4 (2023): 3140.
11. Patel S. “Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy”. The Journal of Steroid Biochemistry and Molecular Biology 182 (2018): 27-36.
12. Rosenfield RL and Ehrmann DA. “The Pathogenesis of Polycystic Ovary Syndrome (PCOS)”. Endocrine Reviews 5 (2016): er.2015-1104.
13. Wang J., et al. “Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome”. Life Science 236 (2019): 116940.
14. Sanchez-Garrido M and Tena-Sempere M. “Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies”. Molecular Metabolism 35 (2020): 100937.
15. Zhang C., et al. “HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS”. FASEB Journal7 (2020): 9563-9574.
16. Kim H., et al. “Insulin regulation of GnRH gene expression through MAP kinase signaling pathways”. Molecular Cell Endocrinology 242 (2005): 42-49.
17. Wallace IR., et al. “Sex hormone binding globulin and insulin resistance”. Clinical Endocrinology (Oxf)3 (2013): 321-329.
18. Ibanez L., et al. “An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence”. Hormone Research in Paediatrics 88 (2017): 371-395.
19. Ianoşi S., et al. “Age-dependent endocrine disorders involved in the pathogenesis of refractory acne in women”. Molecular Medicine Reports 14 (2016): 5501-5506.
20. Li Y., et al. “Tai chi for overweight/obese adolescent and young women with polycystic ovary syndrome: Study protocol for a randomized controlled trial”. Trials 19 (2018): 512.
21. Visser JA., et al. “Increased oocyte degeneration and follicular atresia during the estrous cycle in anti‐Müllerian hormone null mice”. Endocrinology 148 (2007): 2301-230
22. Azziz R., et al. “Polycystic ovary syndrome”. Nature Reviews Disease Primers 2 (2016): 16057.
23. Delitala A., et al. “Polycystic ovary syndrome, adipose tissue and metabolic syndrome”. Archives of Gynecology and Obstetrics 296 (2017): 405-419.
24. Siddiqui S., et al. “A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)”. Journal of Assisted Reproduction and Genetics 11 (2022): 2439-2473.
25. Bednarska S., et al. “The pathogenesis and treatment of polycystic ovary syndrome: What’s new?” Advances in Clinical and Experimental Medicine 26 (2017): 359-367.
26. Jia LY., et al. “The Complementary and Alternative Medicine for Polycystic Ovary Syndrome: A Review of Clinical Application and Mechanism”. Evidence-Based Complementary and Alternative Medicine 2021 (2021): 1-12.
27. McGaugh E and Barthel B. “A Review of Ketogenic Diet and Lifestyle”. Molecular Medicine1 (2022): 84-88.
28. Di Raimondo D., et al. “Ketogenic Diet, Physical Activity, and Hypertension-A Narrative Review”. Nutrients8 (2021): 2567.
29. Dashti H M., et al. “Efficacy of Low-Carbohydrate Ketogenic Diet in the Treatment of Type 2 Diabetes”. Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre,3 (2021): 223-235.
30. Dowis K and Banga S. “The Potential Health Benefits of the Ketogenic Diet: A Narrative Review”. Nutrients5 (2021): 1654.
31. Kikani N and Balasubramanyam A. “Remission in Ketosis-Prone Diabetes”. Endocrinology and Metabolism Clinics of North America 1 (2023): 165-174.
32. Morris G., et al. “Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?” The International Journal of Neuropsychopharmacology 6 (2020): 366-384.
33. Matsuura TR., et al. “Ketones and the Heart: Metabolic Principles and Therapeutic Implications”. Circulation Research7 (2023): 882-898.
34. Dhillon KK and Gupta S. “Biochemistry, Ketogenesis”. [Updated 2023 Feb 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing (2024).
35. Calcaterra V., et al. “Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents”. Nutrients16 (2023): 3582.
36. Karkafi R., et al. “Ketogenic Diet and Inflammation: Implications for Mood and Anxiety Disorders”. Advances in Experimental Medicine and Biology 1411 (20236): 537-554.
37. Paoli A., et al. “Effects of a ketogenic diet in overweight women with polycystic ovary syndrome”. Journal of Translational Medicine 1 (2020): 104.
38. Barrea L., et al. “Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS)”. Current Nutrition Reports1 (2021): 56-64.
39. Cincione R I., et al. “Effects of Mixed of a Ketogenic Diet in Overweight and Obese Women with Polycystic Ovary Syndrome”. International Journal of Environmental Research and Public Health23 (2021): 12490.
40. Meier RK. “Polycystic Ovary Syndrome”. Nursing Clinics of North America3 (2018): 407-420.
41. Li J., et al. “Ketogenic diet in women with polycystic ovary syndrome and liver dysfunction who are obese: A randomized, open-label, parallel-group, controlled pilot trial”. Journal of Obstetrics and Gynaecology Research 3 (2021): 1145-1152.

Citation

Citation: Maria Jimena Barroso Alverde., et al. “A Review on Mastication and Related Factors". Acta Scientific Dental Sciences 7.2 (2025): 03-09.

Copyright

Copyright: © 2025 Maria Jimena Barroso Alverde., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.